PDF(Sci-hub)
Abstract：
Eosinophilic fasciitis is a rare connective tissue disease of unknown etiology. Therapeutic options include high-dose corticosteroids and other immunosuppressive drugs. We present a typical eosinophilic fasciitis case, which did not respond to first-line treatment, but improved remarkably after infliximab administration. This report demonstrates that in case of initial treatment failure, infliximab might be a relatively safe and effective way of eosinophilic fasciitis management.
摘要：
嗜酸性筋膜炎是一种病因不明的罕见结缔组织病。治疗选择包括大剂量皮质类固醇和其他免疫抑制药物。我们提出了一个典型的嗜酸性筋膜炎病例，对一线治疗没有反应，但英夫利昔单抗给药后明显改善。本报告表明，在最初治疗失败的情况下，英夫利昔单抗可能是一种相对安全有效的嗜酸性筋膜炎治疗方法.
